Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cns Pharmaceuticals Inc
CNSPCurrent price
0.11 USD
-0.0003 USD (-0.27%)
Last closed
0.11 USD
Company
www.cnspharma.com
ISIN
US18978H1023
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
5 279 982 USD
Yield for 12 month
-99.69 %
1Y
3Y
5Y
10Y
15Y
CNSP
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. CNS Pharmaceuticals, Inc. has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas. Address: 2100 West Loop South, Houston, TX, United States, 77027
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.50 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-4 134 USD
Last Year
-11 756 USD
Current Quarter
–
Last Quarter
-752 USD
Key Figures CNSP
1 year
3 years
5 years
10 years
EBITDA
-15 982 778 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-224.00 %
PEG Ratio
–
Return On Equity TTM
-1 018.78 %
Wall Street Target Price
0.50 USD
Revenue TTM
–
Book Value
-2.98 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-352.97 USD
Diluted Eps TTM
-352.97 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CNSP
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History CNSP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:50
Payout Ratio
–
Last Split Date
05.06.2024
Dividend Date
–
Stock Valuation CNSP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.40
Price Book MRQ
1.77
Financials CNSP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CNSP
For 52 weeks
0.096 USD
70.00 USD
50 Day MA
0.13 USD
Shares Short Prior Month
683 265
200 Day MA
6.36 USD
Short Ratio
0.040
Shares Short
2 073 962
Short Percent
2.79 %
BeatStart